BioMendics
PrivateLast Round
Seed
Sep 4, 2016
Total Funding Raised
$25,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
BioMendics is a clinical-stage biotechnology company that develops innovative topical therapeutics for rare genetic and dermatologic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioMendics Comparables
Compare BioMendics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mariposa Therapeutics | 85% | |
| CSA Biotechnologies | 82% | |
| Aegle Therapeutics Corp | 80% |
BioMendics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 4, 2016 | ||||
| Grant | Dec 10, 2014 |
BioMendics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovation Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors increased 35% MoM.
- Jan 2, 2026
Monthly visitors increased 80% MoM.
BioMendics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BioMendics's valuation, stock price, and market status.
Is BioMendics a public or private company?
BioMendics is a private company.
What is the current stock price of BioMendics?
BioMendics is a private company with no public stock price. No recent secondary market data is available.
How much is BioMendics worth (valuation)?
Valuation information for BioMendics is not publicly available.
Can I buy BioMendics stock?
BioMendics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BioMendics's last funding round?
BioMendics's most recent funding round was Seed on September 4, 2016.
Who are the main investors in BioMendics?
Key investors in BioMendics include Innovation Fund.
Will BioMendics IPO soon?
No public IPO plans have been announced for BioMendics.
How can I track BioMendics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BioMendics's secondary market activity and sign up for updates.